Assessing the Disease Burden of Non-Alcoholic Fatty Liver Disease in the Real World – Big Data and Big Numbers

BMC Medicine - United Kingdom
doi 10.1186/s12916-019-1357-y
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2019English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Pharmacotherapy of Non-Alcoholic Fatty Liver Disease: Updated Data

Effective Pharmacotherapy
2020English

Non-Alcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease Might Boost Cardiovascular Disease Burden

Archives of Medical Science - Atherosclerotic Diseases
2019English

Differences in the Genetic Backgrounds of Patients With Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease

JGH Open
HepatologyGastroenterology
2018English

The Intensity in Pathogenesis of Mutual Burden of Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease With Obesity

Ukraïnsʹkij žurnal medicini, bìologìï ta sportu
2019English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Recommendations for the Evaluation for Autoimmune Liver Disease in Non-Alcoholic Fatty Liver Disease

Hepatology
MedicineHepatology
2018English

Headway and Hurdles in Non-Alcoholic Fatty Liver Disease

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy